SPF30 sunscreen is a Topical Spray in the Human Otc Drug category. It is labeled and distributed by Yuyao Jessie Commodity Co.,ltd.. The primary component is Octinoxate; Oxybenzone; Octisalate.
Product ID | 51414-104_6207329a-51ee-cbcf-e053-2a91aa0a719d |
NDC | 51414-104 |
Product Type | Human Otc Drug |
Proprietary Name | SPF30 sunscreen |
Generic Name | Octinoxate,oxybenzone,octisalate |
Dosage Form | Spray |
Route of Administration | TOPICAL |
Marketing Start Date | 2012-09-12 |
Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
Application Number | part352 |
Labeler Name | Yuyao Jessie Commodity Co.,Ltd. |
Substance Name | OCTINOXATE; OXYBENZONE; OCTISALATE |
Active Ingredient Strength | 8 g/100g; g/100g; g/100g |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2016-12-11 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-12 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-12-11 |
Ingredient | Strength |
---|---|
OCTINOXATE | 7.5 g/100g |
SPL SET ID: | 435a06e0-5d46-3dce-e054-00144ff88e88 |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
51414-104 | SPF30 sunscreen | Octinoxate,oxybenzone,OCTISALATE |
70412-211 | SPF30 Sunscreen | AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE |
70412-231 | SPF30 Sunscreen | Avobenzone, Homosalate, Octocrylene, Ocitsalate |
70412-238 | SPF30 Sunscreen | Avobenzone, Homosalate, Octocrylene, Ocitsalate |
71642-016 | SPF30 SUNSCREEN | OCTISALATE, OCTISALATE, OXYBENZONE |
51414-600 | SPF15 sunscreen | Octinoxate,oxybenzone,OCTISALATE |